Export 11 results:
Filters: Keyword is multiple sclerosis [Clear All Filters]
Beta-interferon exposure and onset of secondary progressive multiple sclerosis. European Journal of Neurology, 22, pp.990–1000. Available at: http://onlinelibrary.wiley.com/doi/10.1111/ene.12698/abstract., 2015.
Further investigation of safety monitoring guidelines based on magnetic resonance imaging lesion activity in multiple sclerosis clinical trials. Multiple Sclerosis Journal, 21, pp.101-104. Available at: http://msj.sagepub.com/content/early/2014/05/20/1352458514533846., 2015.
Personalized activity index, a new safety monitoring tool for multiple sclerosis clinical trials. Multiple Sclerosis Journal – Experimental, Translational and Clinical, 1, pp.1-15. Available at: http://mso.sagepub.com/content/1/2055217315577829., 2015.
Predictors of disease activity in 857 patients with MS treated with interferon beta-1b. Journal of Neurology, 262, pp.2466-2471., 2015.
Association between beta-interferon exposure and hospital events in multiple sclerosis. Pharmacoepidemiology and Drug Safety, 23, pp.1213-1222., 2014.
Investigation of heterogeneity in the association between interferon beta and disability progression in multiple sclerosis: an observational study. European Journal of Neurology, 21, pp.835–844. Available at: http://onlinelibrary.wiley.com/doi/10.1111/ene.12324/abstract., 2014.
Marginal structural Cox models for estimating the association between beta-interferon exposure and disease progression in a multiple sclerosis cohort. American Journal of Epidemiology, 180, pp.160-171., 2014.
MRI-based clinical trials in relapsing-remitting multiple sclerosis: new sample size calculations based on a longitudinal model. Multiple Sclerosis Journal, 18, pp.1600–1608., 2012.
Natural, innate improvements in multiple sclerosis disability. Multiple Sclerosis Journal, 18, pp.1412-1421., 2012.
Neutralizing antibodies to interferon beta-1b in multiple sclerosis: a clinico-radiographic paradox in the BEYOND trial. Multiple Sclerosis Journal, 18, pp.181-195., 2012.
Magnetic resonance imaging as a surrogate outcome for multiple sclerosis relapses. Multiple Sclerosis, 14, pp.770-778. Available at: http://msj.sagepub.com/content/early/2008/06/05/1352458507088104., 2008.